NightHawk Biosciences announced the promotion of Joe Payne to President and Chief Operating Officer (COO) of its Scorpius BioManufacturing subsidiary. Payne joined Scorpius in 2023 as VP of Quality and Regulatory Affairs. With a biopharma and pharmaceutical career spanning over 20 years, Payne?s recent experience includes leadership roles at CDMOs Tergus Pharma and Alcami Corporation.

He has participated in 40+ regulatory inspections and has extensive knowledge of global regulatory agency requirements. In his role as President and COO, Payne will oversee quality, manufacturing, process sciences, and commercial operations. Mr. Wolf, Mr. Payne and the Scorpius commercial team will be at DCAT Week in New York City on March 18-21 to meet with clients and prospects about analytical testing, process development, and manufacturing services.